ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Abbott Laboratories
(NY:
ABT
)
37.86
USD
+0.05 (+0.13%)
Streaming Delayed Price
/ Updated:
1:16 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
39
40
Next >
Perfect Trade Setups, How to Play LDK, ABT, SPLS and HD
Today 12:00 EDT
from
Marketwired News Releases
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
Today 8:00 EDT
- XIENCE Xpedition™ 48 Leverages Proven Design and Clinical Outcomes of the XIENCE Family of Drug Eluting Stents
Read More
from
PR Newswire
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
Today 5:00 EDT
from
Business Wire News Releases
RBCC Partner n3D Signs U.S. Distribution Agreement
May 13, 2013
from
Business Wire News Releases
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
May 09, 2013
from
PR Newswire
Key to Success, How to Profit: PSX, ABT, UNH and UNP
May 08, 2013
from
Marketwired News Releases
Abbott to Present at UBS Global Healthcare Conference
May 08, 2013
from
PR Newswire
The Reason It Trades, What's Moving ABT, TSN, MDLZ and YHOO
May 07, 2013
from
Marketwired News Releases
World’s Premiere Science Journal Touts Revolutionary Innovations by RBCC Partner Nano3D
May 06, 2013
from
Business Wire News Releases
The Reason It Trades, What's Moving ABT, DE, AMAT and AMT
May 03, 2013
from
Marketwired News Releases
RBCC: Personalized Medicine Poised to Revolutionize Insurance & Pharmaceuticals
April 30, 2013
from
Business Wire News Releases
RBCC Looks Overseas for Potentially Lucrative Licensing Opportunities
April 24, 2013
from
Business Wire News Releases
Insider Trading Review: Newmont Mining, eBay, Cirrus Logic, Nokia, Abbott Laboratories, and Chesapeake Energy
April 18, 2013
from
PR Newswire
Free Research Reports on ABT, GOOG, MU and STJ Issued by the Paragon Report
April 18, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
Abbott Announces FDA Approval and U.S. Launch of the TECNIS® Toric Intraocular Lens for Cataract Patients
April 18, 2013
from
PR Newswire
Abbott Reports First-Quarter 2013 Results
April 17, 2013
- First-Quarter Ongoing EPS of $0.42 (GAAP EPS of $0.34) -
Read More
from
PR Newswire
Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet Increased Testing Demand
April 16, 2013
from
PR Newswire
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® Blood Glucose Meters in the United States
April 15, 2013
At rare, extremely high blood glucose levels (1024 mg/dL and above), the FreeStyle InsuLinx Blood Glucose Meter may provide an inaccurate reading
Read More
from
PR Newswire
RBCC Nears Deal With Leading Genetic Testing Lab
April 15, 2013
from
Business Wire News Releases
Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patients
April 10, 2013
Galectin-3 test may help physicians identify patients at highest risk for a worse prognosis, including re-hospitalization and death, allowing them to tailor the level of care to individual patient...
Read More
from
PR Newswire
Strategy Behind Our Success, We Get in Early: ABT, LOW, TWC and BIDU
April 09, 2013
from
Marketwired News Releases
Key to Success, How to Profit: DELL, LNKD, MA and ABT
April 08, 2013
from
Marketwired News Releases
RBCC Targets Companion Diagnostics Opportunities in Booming $232 Billion Personalized Medicine Market
April 08, 2013
from
Business Wire News Releases
The Straight Truth, Investing in BA, BIDU, MU and ABT
April 08, 2013
from
Marketwired News Releases
Insider Trading for NYSE: Lowe's, Chesapeake Energy, Carnival, Kinross Gold, Comcast, and Abbott Laboratories
April 05, 2013
from
PR Newswire
Perfect Trade Setups, How to Play BA, HTZ, ABT and YUM
April 04, 2013
from
Marketwired News Releases
Morning Research on Boston Scientific, Abbott Laboratories, Medtronic, Zimmer, and EnteroMedics
April 02, 2013
from
PR Newswire
RBCC: New Rainbow BioSciences Website Highlights Impressive Deal Flow
April 02, 2013
from
Business Wire News Releases
Abbott Hosts Conference Call for First-Quarter Earnings
April 01, 2013
from
PR Newswire
New Abbott Test Can Help Doctors Detect the Presence of Two Important Health Issues
March 28, 2013
from
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
39
40
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
6 Healthy Products That Aren't
Diane Bullock
2
Random Thoughts: A Signal That Bears Watching
Todd Harrison
3
Gold Mining Stocks: 10 Reasons It's Time to Be Brave
David Banister
4
Stock Downgrades: Carnival Set to Sink
Justin Sharon
5
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
See All Articles
»
Financial Product Guide